-
公开(公告)号:US20050004232A1
公开(公告)日:2005-01-06
申请号:US10839661
申请日:2004-05-05
IPC分类号: A61K20060101 , A61K31/137 , A61K31/18 , A61K31/24 , A61K31/38 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/425 , A61K31/44 , C07D213/71 , C07D261/04 , C07D285/13
CPC分类号: C07C311/51 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07D213/71 , C07D233/84 , C07D263/46 , C07D277/36 , C07D285/08 , C07D317/40 , C07D333/48 , C07D409/04
摘要: The present invention relates a series of compounds of Formula I wherein R1, R2, R3, and B are as defined in the specification. The compounds are useful for the inhibition of HIV integrase and for the treatment of AIDS or ARC by administering compounds of the formula.
摘要翻译: 本发明涉及一系列式I化合物,其中R 1,R 2,R 3和B如说明书中所定义。 该化合物可用于抑制HIV整合酶和通过施用下式化合物治疗AIDS或ARC。